Skip to main content

Table 2 (A) Clinical presentation and nodal sites on initial presentation (N = 100); (B) organomegaly and extra-nodal sites on initial presentation (N = 100)

From: The clinico-pathological profile of non-Hodgkin’s lymphoma in Aseer region of Saudi Arabia

(A) Patient profile N (%) (B) Patient profile N (%)
Constitutional symptoms Organomegaly (not LNs)
Positive (+ve) 52 (52) Liver 23 (23)
Negative (−ve) 45 (45) Spleen 30 (30)
Unknown 3 (3) Pancreas 1 (1)
Stage of NHL 0 (0) Cecum 1 (1)
I 1 (1) Parotid 2 (2)
I (E) 0 (0) Thyroid 2 (2)
I (S) 2 (2) Kidney 1 (1)
II 4 (4) Ovary 1 (1)
II (E) 0 (0) Stomach 1 (1)
II (S) 3 (3) Colon 0 (0)
III 2 (2) Duodenum 1 (1)
III (E) 1 (1) Brain 1 (1)
III (S) 3 (3)   
III (SE) 25 (25) Presentation with extranodal (primary site other than LNs)  
IV 59 (59) Liver 2 (2)
Unknown   Spleen 0 (0)
Site of lymphadenopathy   Pancreas 0 (0)
Axillary 3 (3) Cecum 3 (3)
Supraclavicular 3 (3) Parotid 1 (1)
Cervical 6 (6) Thyroid 5 (5)
Mesenteric LNs 6 (6) Kidney 2 (2)
Paravertebral 1 (1) Ovary 1 (1)
Epigastric LNs 1 (1) Stomach 13 (13)
Nasopharyngeal 2 (2) Colon 2 (2)
Submandibular 3 (3) Duodenum 1 (1)
Generalized 43 (43) Brain 0 (0)
Retroperitoneal 1 (1) Small bowel 3 (3)
Pre-tracheal 1 (1) Tongue 2 (2)
Unknown 21 (21) Cheek deep tissue 2 (2)
   Bone marrow (BM) 5 (5)
   Eyes 0 (0)
Max. size of lymphadenopathy Skin 1 (1)
< 2 cm 12 (12) Breast 2 (2)
2–4 cm 6 (6) Bones 2 (2)
> 4 cm 31 (31) Jejunum 1 (1)
Unknown 51 (51) Soft tissue 1 (1)